Clinical Trial Update: Phase II Study of Docetaxel Before Degarelix in Patients With Newly Diagnosed Metastatic Prostate Cancer. [Phase 2]

View source ↗

Summary

Phase II study evaluating docetaxel before degarelix in newly diagnosed metastatic prostate cancer; results have been posted in 2025.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• Firmagon (Degarelix)
• Taxotere (docetaxel)

Snippet

Sponsor: Medical University of South Carolina | Conditions: Metastatic Prostatic Adenocarcinoma | Phase 2 | Status: COMPLETED | Results posted: 2025-04-29